跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Eptaplatin
首页
药物
Eptaplatin
Eptaplatin
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Method for preparing platinum(II) metal complex eptaplatin
申请人: NANJING CHEMSOURCE PHARMACEUTI
优先权: 2004
CN
Novel synthesis process of anti-cancer Sunpla
申请人: KUNMING GUIYAN PHARMACEUTICAL
优先权: 2006
CN
An anticancer sustained release injection carrying tumor drug resistance reversal agent and reversal agent synergist
申请人: JINAN KANGQUAN PHARMACEUTICAL
优先权: 2006
CN
An anticancer sustained release injection carrying tumor drug resistance reversal agent and cytotoxic drug simultaneously
申请人: JINAN KANGQUAN PHARMACEUTICAL
优先权: 2006
CN
A compound sustained release anticancer agent containing angiogenesis inhibitor
申请人: JINAN KANGQUAN PHARMACEUTICAL
优先权: 2006
CN
Sustained release anticancer agent carrying angiogenesis inhibitor and cytotoxic drug
申请人: JINAN KANGQUAN PHARMACEUTICAL
优先权: 2006
CN
Anticancer drug composition loading both platinum compound and tetrazole violet
申请人: JINAN SHUAIHUA PHARMACEUTICAL
优先权: 2006
CN
Anti-cancer medicine sustained-release injection loaded with platinum compound and synergist thereof
申请人: SHANDONG LANJIN BIOLOG ENGINEE
优先权: 2006
CN
药物
反馈